Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
4.4
-73.35%
40%
—
-50.92%
80%
—
5 Years
Score4.4
Net Growth-73.35%
Net Trend40%
Net Income Consistency—
Rev Growth-50.92%
Rev Trend80%
Revenue Consistency—
Genmab AS fundamental performance
Between 2020 and 2025, revenue declined from kr 10.11B to kr 3.72B and net income declined from kr 4.75B to kr 963M. Revenue increased in 4 of those 5 years; net income in 2.
Across Genmab AS's full reported history, from 2009 to 2025, revenue grew from kr 586M to kr 3.72B and net income went from -kr 1.01B to kr 963M. Revenue increased in 76% of the years measured; net income in 65%.
Genmab AS currently holds a 5-year HDB Score of 4.4 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 31.42 | — |
1 Year2025-08-12 | $ 21.87 | 43.67% |
5 Years2021-08-12 | $ 46.56 | -32.52% |
10 Years2016-08-12 | $ 17.58 | 78.69% |
All Time2009-06-01 | $ 3.77 | 8x |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2009-06-01 |
|---|---|---|---|---|---|
| Price | $ 31.42 | $ 21.87 | $ 46.56 | $ 17.58 | $ 3.77 |
| Return | — | 43.67% | -32.52% | 78.69% | 8x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | kr 4.13B | kr 788M | kr 1.50B |
| 2025 | kr 3.72B | kr 963M | kr 1.71B |
| 2024 | kr 21.52B | kr 7.84B | kr 21.10B |
| 2023 | kr 16.47B | kr 4.35B | kr 28.13B |
| 2022 | kr 14.50B | kr 5.45B | kr 22.32B |
| 2021 | kr 8.41B | kr 2.95B | kr 19.33B |
| 2020 | kr 10.11B | kr 4.75B | kr 16.07B |
| 2019 | kr 5.36B | kr 2.16B | kr 10.97B |
| 2018 | kr 3.02B | kr 1.47B | kr 6.10B |
| 2017 | kr 2.36B | kr 1.10B | kr 5.42B |
| 2016 | kr 1.81B | kr 1.18B | kr 3.92B |
| 2015 | kr 1.13B | kr 763M | kr 3.49B |
| 2014 | kr 850M | kr 301M | kr 2.66B |
| 2013 | kr 663M | kr 112M | kr 1.55B |
| 2012 | kr 484M | -kr 487M | kr 1.50B |
| 2011 | kr 350M | -kr 596M | kr 1.10B |
| 2010 | kr 582M | -kr 321M | kr 1.64B |
| IPO2009 | kr 586M | -kr 1.01B | kr 1.27B |
Explore beyond GMAB
You're looking at Genmab AS. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
